So here we're going to begin our lesson on Insulin Growth Factor Signaling via the RAS pathway, and we'll introduce what this RAS pathway is here very shortly. Now first, we need to recall from our previous lesson videos that insulin results in an active and phosphorylated Insulin Receptor Substrate 1 or IRS 1. And so just as a reminder, notice over here on the left-hand side of our image, we're showing you the 51 amino acid peptide hormone, insulin, binding to the insulin receptor. When insulin binds to the insulin receptor, it activates the autophosphorylation of the beta domains. These beta domains are Tyrosine Kinase domains, and they phosphorylate Tyrosine residues on each other. That fully activates the Tyrosine Kinase domains here so that it can phosphorylate its substrate, insulin receptor substrate 1 or IRS 1, which leads to again an active and phosphorylated IRS 1 protein. This is a reminder from our previous lesson videos. We already knew that insulin would lead to active IRS 1. This is again a recall from our previous lesson videos that insulin results in active IRS 1. And really, this is exactly where we pick up with when we start the RAS pathway. We start the RAS pathway with an active IRS 1. Even though we're starting the RAS pathway with active IRS 1, we still can't forget the previous steps here of the RTK, the insulin binding, the autophosphorylation, and again the phosphorylation of IRS into IRS 1. This is just a reminder again from our previous lesson videos.
Now also recall from our previous lesson videos that active IRS one really acts as a branch point in insulin biosignaling. It can lead to many different pathways. You might recall in our previous lesson videos, we saw active IRS 1 in insulin signaling on glucose metabolism. Here we're going to see active IRS 1 once again, but this time it's not going to be involved in glucose metabolism. It's going to be involved in growth factor signaling. Again, IRS 1 can act as a branch point in insulin biosignaling and can lead to many different pathways, including this RAS pathway that we're about to introduce here.
So what is this RAS here that the RAS pathway is referring to? Well, Ras is actually a lipid linked monomeric g protein. But wait a second, I thought you said that g proteins were involved with GPCRs, g protein coupled receptors. Not with RTKs like the insulin receptor that we have below. It turns out that the Ras g protein is an exception to this. Ras is a G Protein that is not involved with GPCRs; instead, it's involved with the Insulin RTK, a receptor tyrosine kinase. Another difference is in our previous lesson videos with the GPCRs, the g proteins were heterotrimeric g proteins, meaning that they had 3 different subunits, the alpha, beta, and gamma subunits. But notice that this g protein here in Ras is not a heterotrimeric g protein. Instead, it's a monomeric g protein, meaning that it only has one single subunit instead of 3 different subunits. This Ras g protein, monomeric g protein, exists in two forms as you might expect. It exists in a GDP bound form, which is the inactive form, and it also exists in a GTP bound form, which is the active form. This is important to keep in mind as we move along and talk more about this RAS pathway.
Really the ras pathway is a 3 step cascade of protein interactions, and these three steps really lead to the activation of this rasg protein during insulin signaling as a growth factor. Notice down below, we have each of the 3 steps in this cascade numbered in our text, and of course, the numbers that you see here in our text correspond with the numbers that you see below in our image. In the very first step of this RAS pathway, pathway, again, we're starting with active IRS 1, and so we're starting right here at this portion of our image. The active IRS 1 is going to serve as a binding site, as an adapter protein for the SH2 domain of the adapter protein called GRB2. If we take a look at our image below, notice that IRS 1 over here is acting as an adapter protein, and the SH2 domain of this protein right here, which is GRB2, is binding to the phosphorylated tyrosine residue on IRS 1, and this is going to activate GRB2, which is another adapter protein. As we indicated above, GRB2 is an adapter protein. This leads us to step number 2, and that is that GRB2's SH3 domain, which is on the opposite side of the protein, is going to serve as a binding site for another protein called SARS. When it binds to GRB2, it's going to form an IRS 1, GRB2 SARS complex since they're all binding to one another. If we take a look at our step number 2 below, notice that the SH2 domain of GRB2 is binding to IRS 1. However, on the opposite end, we have an SH3 domain on GRB2 that is binding to this other orange protein over here that we're calling SARS. Now what we have is an IRS 1, GRB2, and SARS complex after step number 2, as we indicated above.
So then that leads us to step number 3, and what's important to note is that the bound SARS protein is actually a guanine exchange factor, which you can see by these bolded letters here is abbreviated as a GEF or Gef protein. The sauce, because it is a guanine exchange factor, is going to allow for the guanine exchange in our g protein. It's going to catalyze the replacement of GDP, the low energy inactive form, with GTP, the high energy active form, on our ras monomeric g protein. Notice below in our image in step number 3 right here that we have this green protein right here, which is a monomeric g protein called Ras. Ras is in its inactive state right here originally, where it is bound to GDP. But when SARS is bound to GRB2 and SARS becomes activated, SARS can then act as the guanine exchange factor that it is or the Geth that it is, it's going to catalyze the replacement of GDP with GTP to activate RAS. You can see that we have GTP replacing GDP here in the ras protein. And of course, here we have the ras bound to GTP, which is the active form of our ras monomeric g protein. This active ras will actually regulate cell growth via activation of another signaling pathway called the mapk signaling cascade or the mapk signaling pathway. Notice that here we're showing how RAS, the active form of RAS, will activate another pathway called the map K signal cascade. We'll talk about this map K signal cascade in our next lesson video. But for now, this here actually concludes the ras pathway. The ras pathway ends with an active rasg protein.
Now what's also important to note here is that very similar pathways to the one that we just discussed above where IRS 1 activates GRB 2, activating SARS, activating RAS. Very similar pathways can also be initiated by other signaling molecules other than insulin. So they can be initiated by a variety of other growth factors, such as for example, EGF, or epidermal growth factor, or PDGF, or platelet-derived growth factor. Here we have these abbreviations for you. You may see in some of your textbooks that insulin does not act as the ligand for this pathway, but instead, perhaps it is again epidermal growth factor or EGF or perhaps even PDGF, platelet-derived growth factor, which again can stimulate very similar pathways to the one that we discussed above. But this here concludes our introduction to the insulin growth factor signaling via the RAS pathway and we'll be able to get some practice applying this as we move along. And of course, later we'll continue to talk about the mat K signaling cascade as well. So I'll see you guys in our next video.